A preliminary investigation of Tanakan in the treatment of hypertensive arteriosclerosis and stroke in rats

Chinese Medical Journal

Volumn 113, Issue 5, 2000, Pages 425-428

  Fang, Yannan ^a   Huang, Ruxun ^a   Zhang, Yan ^a   Lin, Jianwen ^a   Li, Jinru ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Arteriosclerosis stroke; Gingko biloba; Hypertension

Indexed keywords

GINKGO BILOBA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HISTOPATHOLOGY; HYPERTENSION; MALE; NONHUMAN; RAT; STROKE;

ANIMALS; CEREBROVASCULAR ACCIDENT; GINKGO BILOBA; HYPERTENSION; INTRACRANIAL ARTERIOSCLEROSIS; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; VASODILATOR AGENTS;

EID: 0034075269     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Zeng JS, Zhang YQ, Mo JW, et al. Two-kidney, two clip renovascular hypertensive rats can be used as stroke-prone rats. Stroke 1998;29:1708-1715.
2. Han DK, Haudenschild C, Hong MK, et al. Evidence for apoptosis in atherogenesis. AJP 1995;147:267-271.
3. Gibbon GH, Dzau VJ. Molecular therapies for vascular disease. Science 1996;272:689-697.
4. Peng Y, Huang RX, Liu ZL, et al. The dynamic changes of angiotensin II and atrial natriuretic factor levels in hypothalamus and infarct volume of rats with focal cerebral ischemia. J Med Coll PLA 1995;10:277-281.
5. Guinot P, Caffrey E, Lambe R, et al. Tanakan inhibits platelet-activating-factor-induced platelet aggregation in healthy male volunteers. Haemostasis 1989;19:219-223.
6. Antiplatelet Trialists Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988; 296:320-326.
7. Moro MA, Russel RJ, Cellek S, et al. CGMP mediates the vascular and platelet actions of nitric oxide. Proc Natl Acad Sci U S A 1996;93:1480-1487.